Cargando…

EGCG binds intrinsically disordered N-terminal domain of p53 and disrupts p53-MDM2 interaction

Epigallocatechin gallate (EGCG) from green tea can induce apoptosis in cancerous cells, but the underlying molecular mechanisms remain poorly understood. Using SPR and NMR, here we report a direct, μM interaction between EGCG and the tumor suppressor p53 (K(D) = 1.6 ± 1.4 μM), with the disordered N-...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Jing, Blayney, Alan, Liu, Xiaorong, Gandy, Lauren, Jin, Weihua, Yan, Lufeng, Ha, Jeung-Hoi, Canning, Ashley J., Connelly, Michael, Yang, Chao, Liu, Xinyue, Xiao, Yuanyuan, Cosgrove, Michael S., Solmaz, Sozanne R., Zhang, Yingkai, Ban, David, Chen, Jianhan, Loh, Stewart N., Wang, Chunyu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7881117/ https://www.ncbi.nlm.nih.gov/pubmed/33579943 http://dx.doi.org/10.1038/s41467-021-21258-5

Ejemplares similares

Energetic Landscape of MDM2-p53 Interactions by Computational Mutagenesis of the MDM2-p53 Interaction
por: Thayer, Kelly M., et al.
Publicado: (2016)

Detection of P53 and Mdm2 in vitiligo
por: Wiwanitkit, Viroj
Publicado: (2013)

The MDM2-p53 pathway revisited
por: Nag, Subhasree, et al.
Publicado: (2013)

Evolution of the p53-MDM2 pathway
por: Åberg, Emma, et al.
Publicado: (2017)

Novel Allosteric Mechanism of Dual p53/MDM2 and p53/MDM4 Inhibition by a Small Molecule
por: Grinkevich, Vera V., et al.
Publicado: (2022)

EGCG Enhanced the Anti-tumor Effect of Doxorubicine in Bladder Cancer via NF-κB/MDM2/p53 Pathway
por: Luo, Ke-Wang, et al.
Publicado: (2020)

Modulation of p53 Transactivation Domain Conformations by Ligand Binding and Cancer-Associated Mutations
por: Liu, Xiaorong, et al.
Publicado: (2020)

Mdm2 RING Mutation Enhances p53 Transcriptional Activity and p53-p300 Interaction
por: Clegg, Hilary V., et al.
Publicado: (2012)

Regulation of p53: a collaboration between Mdm2 and MdmX
por: Pei, Dongsheng, et al.
Publicado: (2012)

Regulation of kidney development by the Mdm2/Mdm4–p53 axis
por: El-Dahr, Samir, et al.
Publicado: (2017)

The RP-Mdm2-p53 Pathway and Tumorigenesis
por: Miliani de Marval, Paula L., et al.
Publicado: (2011)

Controlling the Mdm2-Mdmx-p53 Circuit
por: Waning, David L., et al.
Publicado: (2010)

Immunohistochemical detection of P53 and Mdm2 in vitiligo
por: Bakry, Ola A., et al.
Publicado: (2012)

Heterogeneous Hydration of p53/MDM2 Complex
por: Guo, Zuojun, et al.
Publicado: (2014)

Reactivation of p53 via MDM2 inhibition
por: Kim, E S, et al.
Publicado: (2015)

Fortifying p53 – beyond Mdm2 inhibitors
por: Sriraman, Anusha, et al.
Publicado: (2016)

Structural Basis of Competitive Recognition of p53 and MDM2 by HAUSP/USP7: Implications for the Regulation of the p53–MDM2 Pathway
por: Hu, Min, et al.
Publicado: (2006)

Effects of p53 mutants derived from lung carcinomas on the p53-responsive element (p53RE) of the MDM2 gene.
por: Gorgoulis, V. G., et al.
Publicado: (1998)

The Dual Interactions of p53 with MDM2 and p300: Implications for the Design of MDM2 Inhibitors
por: Kannan, Srinivasaraghavan, et al.
Publicado: (2019)

Simultaneous measurement of p53:Mdm2 and p53:Mdm4 protein-protein interactions in whole cells using fluorescence labelled foci
por: Frosi, Y., et al.
Publicado: (2019)

Dissecting the p53-Mdm2 feedback loop in vivo: uncoupling the role in p53 stability and activity
por: Pant, Vinod, et al.
Publicado: (2014)

Explaining oscillations and variability in the p53-Mdm2 system
por: Proctor, Carole J, et al.
Publicado: (2008)

Targeting the p53–MDM2 interaction to treat cancer
por: Klein, C, et al.
Publicado: (2004)

The Role of p53 and MDM2 in Head and Neck Cancer
por: Denaro, N., et al.
Publicado: (2011)

p53 AND MDM2 PROTEIN EXPRESSION IN ACTINIC CHEILITIS
por: de Freitas, Maria da Conceição Andrade, et al.
Publicado: (2008)

Artificial Macrocycles as Potent p53–MDM2 Inhibitors
por: Estrada-Ortiz, Natalia, et al.
Publicado: (2017)

Rewired Notch/p53 by Numb’ing Mdm2
por: Kim, Hyungsoo, et al.
Publicado: (2018)

Targeting the MDM2-p53 pathway in dedifferentiated liposarcoma
por: Traweek, Raymond S., et al.
Publicado: (2022)

p53 and Zinc: A Malleable Relationship
por: Ha, Jeung-Hoi, et al.
Publicado: (2022)

The p53–Mdm2 feedback loop protects against DNA damage by inhibiting p53 activity but is dispensable for p53 stability, development, and longevity
por: Pant, Vinod, et al.
Publicado: (2013)

Benzimidazoles Downregulate Mdm2 and MdmX and Activate p53 in MdmX Overexpressing Tumor Cells
por: Mrkvová, Zuzana, et al.
Publicado: (2019)

Diaryl- and triaryl-pyrrole derivatives: inhibitors of the MDM2–p53 and MDMX–p53 protein–protein interactions
por: Blackburn, Tim J., et al.
Publicado: (2013)

NAT10 regulates p53 activation through acetylating p53 at K120 and ubiquitinating Mdm2
por: Liu, Xiaofeng, et al.
Publicado: (2016)

Targeting Post-Translational Regulation of p53 in Colorectal Cancer by Exploiting Vulnerabilities in the p53-MDM2 Axis
por: Lai, Chunwei W., et al.
Publicado: (2022)

Reconstitution of Mdm2-Dependent Post-Translational Modifications of p53 in Yeast
por: Di Ventura, Barbara, et al.
Publicado: (2008)

HIPK2 overexpression leads to stabilization of p53 protein and increased p53 transcriptional activity by decreasing Mdm2 protein levels
por: Wang, Ying, et al.
Publicado: (2001)

Functional interplay between MDM2, p63/p73 and mutant p53
por: Stindt, M H, et al.
Publicado: (2015)

Abnormalities of the p53 MDM2 and DCC genes in human leiomyosarcomas.
por: Patterson, H., et al.
Publicado: (1994)

Stress-specific response of the p53-Mdm2 feedback loop
por: Hunziker, Alexander, et al.
Publicado: (2010)

A Theoretical Exploration of Birhythmicity in the p53-Mdm2 Network
por: Abou-Jaoudé, Wassim, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_fa4ghhh6dn9efppo035pn7h1jt